Bacterin to Receive $1.4 Million From Defense Appropriation for Antimicrobial Coatings for Medical Devices
BELGRADE, Mont. -- Bacterin International, Inc., a
developer and manufacturer of elutive bioactive coatings for medical devices, announced today that the Department of Defense has awarded the company $1.4 million in DOD appropriations to develop anti-microbial coatings for
medical devices. Should the company succeed in developing a coating under the appropriations project, Bacterin officials hope to turn the project into a contract with the DOD.
Guy Cook, president of Bacterin, said, "Three-fourths of all battlefield injuries today are open fractures to a soldier's arms or legs. MASH units treating these soldiers must use temporary measures to transport casualties
from the battlefield to military hospitals for full care. Unfortunately, by the time these soldiers reach definitive care, multiple organisms have infected nearly 70 percent of these open wounds. Under our DOD Appropriations project, we will be working to add bioactive coatings to temporary orthopedic fixation devices used to treat battlefield wounds. Anti-inflammatory, anti-infective, anti-coagulant, or pain relief properties embedded in a
bioactive coating could significantly reduce the high rate of infection seen
in medical devices currently implanted under battlefield conditions. Coated
medical devices could reduce pain and suffering, and possibly save limbs, even
lives."
Bacterin has pioneered biofilm science since its founding in 1997.
Initially, Bacterin served as one of the industry's leading independent
testing facilities for the world's largest medical device manufacturers.
Today the company manufactures and licenses its own proprietary bioactive
coating technology with diverse applications in multiple medical settings.
Bacterin's anti-infective coating prevents microbial (biofilm) formation and
growth, thereby reducing bacterial adhesion associated with invasive medical
devices and surgical procedures. The company is actively pursuing licensing
agreements with several major medical device manufacturers.
SOURCE Bacterin International, Inc.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
